Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK
ARCK was delisted on the 12th of January, 2023.
62 hedge funds and large institutions have $152M invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
10% more capital invested
Capital invested by funds: $139M → $152M (+$13.4M)
5% more funds holding
Funds holding: 59 → 62 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$5.05M |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
+$3.53M |
| 3 |
CC
Centiva Capital
New York
|
+$2.81M |
| 4 |
ACM
Atalaya Capital Management
New York
|
+$2.64M |
| 5 |
SCM
Saba Capital Management
New York
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$9.09M |
| 2 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$5.02M |
| 3 |
Goldman Sachs
New York
|
-$1.96M |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
-$1.57M |
| 5 |
ECU
Eisler Capital (UK)
London,
United Kingdom
|
-$1.51M |
ARCK Hedge Fund Activity: Q3 2022 in Review
62 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q3 2022, worth a combined $152M — up 9.6% from $139M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ARCK positions and 7 closed out — a net gain of 3 holders — while 16 added to existing stakes and 8 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $5.05M. The largest seller was Cantor Fitzgerald, cutting an estimated $9.09M.
- 62 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q3 2022, up from 59 in Q2 2022.
- Funds reported $152M of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q3 2022, up 9.6% quarter-over-quarter.
- 10 funds opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q3 2022 and 7 closed out, a net change of +3 holders.
- The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q3 2022 was Janus Henderson Group, an estimated $5.05M added.
- The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock seller in Q3 2022 was Cantor Fitzgerald, an estimated $9.09M sold.
Based on aggregated 13F filings for Q3 2022.